Overview

Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS

Status:
Completed
Trial end date:
2017-10-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn about the pharmacokinetics and pharmacodynamics of RPC1063 in RMS.
Phase:
Phase 1
Details
Lead Sponsor:
Celgene
Treatments:
Ozanimod